0.3388
price up icon3.16%   0.0099
 
loading

Finanzdaten der Prophase Labs Inc-Aktie (PRPH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
157.61%
1.431
-2.484 3.146 2.474 3.634
Cost Of Revenue
126.56%
0.905
-3.408 3.311 2.95 4.067
Gross Profit
43.07%
0.526
0.924 -0.165 -0.476 -0.433
Operating Expenses
72.96%
4.189
15.49 7.772 7.351 7.865
Benefits Costs and Expenses
54.68%
6.109
13.48 12.24 10.91 12.46
Costs And Expenses
54.68%
6.109
13.48 12.24 10.91 12.46
Depreciation and Amortization
25.33%
1.141
1.528 1.522 1.532 1.605
Operating Income/Loss
74.85%
-3.663
-14.57 -7.937 -7.827 -8.298
Income/Loss From Continuing Operations Before Tax
70.70%
-4.678
-15.96 -9.095 -8.44 -8.831
Income Tax Expense/Benefit
100.00%
-
14.56 -2.508 -2.287 -2.566
Income/Loss From Continuing Operations After Tax
84.67%
-4.678
-30.52 -6.587 -6.153 -6.265
Income/Loss From Discontinued Operations, Net Of Tax
8.644
- - - -
Net Income/Loss
111.54%
3.966
-34.36 -6.587 -6.153 -6.265
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,867%
35.23
1.791 19.08 18.89 18.05
Diluted Average Shares
1,867%
35.23
1.791 19.08 18.89 18.05
Basic Earnings Per Share
106.92%
0.11
-1.59 -0.35 -0.33 -0.35
Diluted Earnings Per Share
106.92%
0.11
-1.59 -0.35 -0.33 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$291.98
price down icon 0.87%
diagnostics_research DGX
$178.36
price down icon 0.81%
diagnostics_research LH
$274.71
price down icon 1.67%
$167.20
price up icon 2.50%
diagnostics_research MTD
$1,292.52
price up icon 0.59%
diagnostics_research IQV
$187.15
price down icon 0.91%
Kapitalisierung:     |  Volumen (24h):